TMEM184A

gene
On this page

Also known as MGC9712SDMG1SLC51C1

Summary

TMEM184A (transmembrane protein 184A, HGNC:28797) is a protein-coding gene on chromosome 7p22.3, encoding Transmembrane protein 184A (Q6ZMB5). Acts as a heparin receptor in vascular cells.

Predicted to enable heparin binding activity and transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to act upstream of or within germ-line sex determination; regulation of protein localization; and regulation of secretion. Predicted to be located in cytoplasmic vesicle; perinuclear region of cytoplasm; and plasma membrane. Predicted to be active in early endosome membrane.

Source: NCBI Gene 202915 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 85 total
  • MANE Select transcript: NM_001097620

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28797
Approved symbolTMEM184A
Nametransmembrane protein 184A
Location7p22.3
Locus typegene with protein product
StatusApproved
AliasesMGC9712, SDMG1, SLC51C1
Ensembl geneENSG00000164855
Ensembl biotypeprotein_coding
Entrez202915

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 15 protein_coding, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 2 retained_intron

ENST00000297477, ENST00000319010, ENST00000319018, ENST00000414730, ENST00000421923, ENST00000421996, ENST00000431208, ENST00000441933, ENST00000449955, ENST00000468535, ENST00000474813, ENST00000910336, ENST00000910337, ENST00000910339, ENST00000910340, ENST00000910342, ENST00000910344, ENST00000910345, ENST00000943039, ENST00000943040, ENST00000943041

RefSeq mRNA: 1 — MANE Select: NM_001097620 NM_001097620

CCDS: CCDS43537

Canonical transcript exons

ENST00000297477 — 9 exons

ExonStartEnd
ENSE0000123964115422351547181
ENSE0000165072315552661555484
ENSE0000176776915561141556205
ENSE0000350987315485191548688
ENSE0000352178415508171550982
ENSE0000353608715477421547939
ENSE0000363706515498541549945
ENSE0000366938115501231550198
ENSE0000378786215503051550395

Expression profiles

Bgee: expression breadth ubiquitous, 230 present calls, max score 98.47.

FANTOM5 (CAGE): breadth broad, TPM avg 3.1632 / max 90.4549, expressed in 434 samples.

FANTOM5 promoters (8 alternative TSS)

Promoter IDTPM avgSamples expressed
824300.8285244
824290.5000218
824330.4801157
824310.4257198
824270.3633182
824280.3431188
824260.1990104
824320.02368

Top tissues by expression

254 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583498.47gold quality
esophagus mucosaUBERON:000246996.45gold quality
right uterine tubeUBERON:000130294.37gold quality
buccal mucosa cellCL:000233693.20silver quality
vena cavaUBERON:000408792.76gold quality
skin of abdomenUBERON:000141692.44gold quality
skin of legUBERON:000151191.85gold quality
tendon of biceps brachiiUBERON:000818891.33silver quality
mucosa of transverse colonUBERON:000499190.96gold quality
parotid glandUBERON:000183190.62gold quality
right lobe of liverUBERON:000111490.48gold quality
body of pancreasUBERON:000115090.14gold quality
pharyngeal mucosaUBERON:000035589.76gold quality
zone of skinUBERON:000001489.51gold quality
body of tongueUBERON:001187688.05gold quality
nasal cavity epitheliumUBERON:000538487.85gold quality
cerebellar vermisUBERON:000472087.81silver quality
duodenumUBERON:000211487.32gold quality
saliva-secreting glandUBERON:000104487.12gold quality
minor salivary glandUBERON:000183086.48gold quality
mouth mucosaUBERON:000372986.18gold quality
esophagus squamous epitheliumUBERON:000692085.98gold quality
vaginaUBERON:000099685.94gold quality
olfactory segment of nasal mucosaUBERON:000538685.86gold quality
tracheaUBERON:000312685.84gold quality
lateral nuclear group of thalamusUBERON:000273685.81silver quality
tongueUBERON:000172385.17gold quality
substantia nigra pars compactaUBERON:000196585.03gold quality
lateral globus pallidusUBERON:000247684.89gold quality
nippleUBERON:000203084.71gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.03

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • TMEM184A functions as a heparin receptor and mediates anti-inflammatory responses of endothelial cells involving decreased JNK and p38 activity. (PMID:26769965)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotmem184aENSDARG00000104538
mus_musculusTmem184aENSMUSG00000036687
rattus_norvegicusTmem184aENSRNOG00000001275
caenorhabditis_elegansWBGENE00009574

Paralogs (3): SLC51A (ENSG00000163959), TMEM184C (ENSG00000164168), TMEM184B (ENSG00000198792)

Protein

Protein identifiers

Transmembrane protein 184AQ6ZMB5 (reviewed: Q6ZMB5)

All UniProt accessions (7): B7WNT3, C9J4I0, C9JDD9, C9JKG9, Q6ZMB5, F8W8F1, F8WEG1

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a heparin receptor in vascular cells. May be involved in vesicle transport in exocrine cells and Sertoli cells.

Subcellular location. Cell membrane. Cytoplasm. Perinuclear region. Cytoplasmic vesicle membrane. Early endosome membrane. Endosome. Cytoplasmic vesicle. Secretory vesicle membrane.

Tissue specificity. Expressed in vascular cells (at protein level).

Similarity. Belongs to the TMEM184 family.

RefSeq proteins (1): NP_001091089* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR005178Ostalpha/TMEM184CFamily

Pfam: PF03619

UniProt features (12 total): transmembrane region 7, sequence variant 2, chain 1, sequence conflict 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZMB5-F173.240.24

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 86 (showing top): RNGTGGGC_UNKNOWN, GOCC_SECRETORY_GRANULE, GCANCTGNY_MYOD_Q6, CAGCTG_AP4_Q5, chr7p22, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, GOMF_GLYCOSAMINOGLYCAN_BINDING, RYTTCCTG_ETS2_B, GOMF_HEPARIN_BINDING, NIKOLSKY_BREAST_CANCER_7P22_AMPLICON, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_SECRETORY_VESICLE, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, GOCC_EARLY_ENDOSOME_MEMBRANE, GOCC_SECRETORY_GRANULE_MEMBRANE

GO Biological Process (1): transmembrane transport (GO:0055085)

GO Molecular Function (2): heparin binding (GO:0008201), transmembrane transporter activity (GO:0022857)

GO Cellular Component (10): endosome (GO:0005768), plasma membrane (GO:0005886), transport vesicle membrane (GO:0030658), cytoplasmic vesicle membrane (GO:0030659), secretory granule membrane (GO:0030667), early endosome membrane (GO:0031901), perinuclear region of cytoplasm (GO:0048471), cytoplasm (GO:0005737), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
cytoplasmic vesicle2
cytoplasmic vesicle membrane2
bounding membrane of organelle2
cytoplasm2
transport1
cellular process1
glycosaminoglycan binding1
sulfur compound binding1
transporter activity1
transmembrane transport1
endomembrane system1
membrane1
cell periphery1
transport vesicle1
vesicle membrane1
secretory granule1
early endosome1
endosome membrane1
intracellular anatomical structure1
intracellular vesicle1

Protein interactions and networks

STRING

540 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM184AKCTD14Q9BQ13607
TMEM184ATMEM190Q8WZ59509
TMEM184ADNAI3Q8IWG1502
TMEM184ATINAGL1Q9GZM7467
TMEM184AOR56A3Q8NH54445
TMEM184AERICH4A6NGS2443
TMEM184ATMEM128Q5BJH2419
TMEM184ATMEM214Q6NUQ4414
TMEM184ALRRCC1Q9C099404
TMEM184ATRPV4Q9HBA0377
TMEM184AAMBNQ9NP70362
TMEM184AINSL3P51460352
TMEM184ATMEM245Q9H330352
TMEM184APARM1Q6UWI2346
TMEM184AGSTO2Q9H4Y5342

IntAct

7 interactions, top by confidence:

ABTypeScore
TMEM184ASLC33A1psi-mi:“MI:0914”(association)0.530
TMEM184AAHNAKpsi-mi:“MI:0915”(physical association)0.400
TMEM184ARCHY1psi-mi:“MI:0915”(physical association)0.370
TMEM184ANRDCpsi-mi:“MI:0914”(association)0.350

BioGRID (118): TMEM184A (Affinity Capture-RNA), ALDH4A1 (Affinity Capture-MS), PDP2 (Affinity Capture-MS), HIBCH (Affinity Capture-MS), GTF2F2 (Affinity Capture-MS), ME2 (Affinity Capture-MS), YARS2 (Affinity Capture-MS), IBA57 (Affinity Capture-MS), KCTD15 (Affinity Capture-MS), RBM38 (Affinity Capture-MS), ASS1 (Affinity Capture-MS), RRM1 (Affinity Capture-MS), ISCU (Affinity Capture-MS), BAIAP2L1 (Affinity Capture-MS), NRD1 (Affinity Capture-MS)

ESM2 similar proteins: A2VDL9, A9UY97, F4JY11, G4YM00, G4Z2L3, O17204, O42579, P15920, P16393, P20715, P30628, P36142, P54960, P70549, P93766, Q09906, Q18071, Q1RMW2, Q29BL9, Q2U0S9, Q3UF25, Q3UFJ6, Q4QQS1, Q54PI4, Q54WM0, Q5BPZ5, Q5FWM8, Q5RBL0, Q5XIT3, Q5Z413, Q61086, Q651J5, Q657S5, Q6P6G5, Q6VVA6, Q6ZMB5, Q7TSW6, Q86TL2, Q8BG09, Q8MRQ4

Diamond homologs: A2VDL9, Q09906, Q17QL9, Q1RMW2, Q28CV2, Q3TPR7, Q3UFJ6, Q4QQS1, Q54PI4, Q54WM0, Q5BPZ5, Q5RET6, Q5ZMP3, Q6GQE1, Q6ZMB5, Q75JN3, Q810F5, Q8BG09, Q9NVA4, Q9Y519, F4JTN2, Q94CA0, P36142

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

85 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign6
Benign4

Top pathogenic / likely-pathogenic (0)

SpliceAI

1975 predictions. Top by Δscore:

VariantEffectΔscore
7:1547002:T:TAdonor_gain1.0000
7:1548687:CA:Cacceptor_gain1.0000
7:1548689:C:CCacceptor_gain1.0000
7:1549852:A:ACdonor_gain1.0000
7:1549853:C:CCdonor_gain1.0000
7:1550118:CTCA:Cdonor_loss1.0000
7:1550121:A:Cdonor_loss1.0000
7:1550122:CCT:Cdonor_loss1.0000
7:1550303:A:ACdonor_gain1.0000
7:1550304:C:CCdonor_gain1.0000
7:1550392:AAGG:Aacceptor_gain1.0000
7:1550393:AGG:Aacceptor_gain1.0000
7:1550394:GG:Gacceptor_gain1.0000
7:1550396:C:CCacceptor_gain1.0000
7:1550812:CCCA:Cdonor_loss1.0000
7:1550813:CCAC:Cdonor_loss1.0000
7:1550814:CA:Cdonor_loss1.0000
7:1550815:ACC:Adonor_loss1.0000
7:1550978:TAGAT:Tacceptor_gain1.0000
7:1555260:GCTTA:Gdonor_loss1.0000
7:1555261:CTTAC:Cdonor_loss1.0000
7:1555262:TTAC:Tdonor_loss1.0000
7:1555263:TAC:Tdonor_loss1.0000
7:1555264:A:Cdonor_loss1.0000
7:1555265:C:Adonor_loss1.0000
7:1546959:T:TAdonor_gain0.9900
7:1547182:C:CCacceptor_gain0.9900
7:1547736:GTGTA:Gdonor_loss0.9900
7:1547737:TGTA:Tdonor_loss0.9900
7:1547739:TA:Tdonor_loss0.9900

AlphaMissense

2680 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:1548637:G:CS232R0.997
7:1548637:G:TS232R0.997
7:1548639:T:GS232R0.997
7:1550126:C:AK183N0.996
7:1550126:C:GK183N0.996
7:1549931:G:CF189L0.995
7:1549931:G:TF189L0.995
7:1549933:A:GF189L0.995
7:1549938:A:GL187P0.995
7:1550376:G:CF135L0.995
7:1550376:G:TF135L0.995
7:1550378:A:GF135L0.995
7:1547096:G:CN366K0.994
7:1547096:G:TN366K0.994
7:1547107:C:GA363P0.994
7:1550368:A:GL138P0.994
7:1550379:G:CS134R0.994
7:1550379:G:TS134R0.994
7:1550381:T:GS134R0.994
7:1550941:T:AQ87H0.993
7:1550941:T:GQ87H0.993
7:1547782:G:CF324L0.992
7:1547782:G:TF324L0.992
7:1547784:A:GF324L0.992
7:1547824:G:CC310W0.992
7:1549919:C:AK193N0.992
7:1549919:C:GK193N0.992
7:1549945:C:GA185P0.992
7:1548547:T:AK262N0.991
7:1548547:T:GK262N0.991

dbSNP variants (sampled 300 via entrez): RS1000028094 (7:1552429 C>A,T), RS1000036040 (7:1544148 C>T), RS1000162679 (7:1555513 G>A,C), RS1000278337 (7:1555673 C>T), RS1000364926 (7:1547295 G>A,C), RS1000837108 (7:1548231 C>A,G,T), RS1000995920 (7:1544642 C>G,T), RS1001044505 (7:1555625 G>A), RS1001069436 (7:1551699 G>A), RS1001433605 (7:1551458 A>G), RS1001474082 (7:1554519 A>G), RS1001540697 (7:1551901 C>T), RS1001582978 (7:1547567 C>T), RS1001968638 (7:1551702 C>T), RS1002071299 (7:1555875 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

17 total (human), top 17 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatinaffects cotreatment, decreases expression2
Cadmium Chloridedecreases expression, increases expression2
FR900359decreases phosphorylation1
bisphenol Adecreases methylation1
ethyl-p-hydroxybenzoateincreases expression1
sodium arsenitedecreases expression1
perfluoro-n-nonanoic acidincreases expression1
abrineincreases expression1
jinfukangaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Arsenicaffects methylation1
Benzo(a)pyrenedecreases methylation1
Estradiolaffects cotreatment, decreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.